Top Story

Pegloticase effective for rapid resolution of tophi in gout

January 15, 2019
FDA News

FDA panel: Febuxostat benefits outweigh CV risks, but reduce use

January 14, 2019
A joint panel of the FDA’s Arthritis Advisory Committee and Drug Safety and Risk Management Advisory Committee voted 19-2 with one abstention that patient…
In the JournalsPerspective

Bone erosions detected in 44% of patients with gout

December 27, 2018
Researchers using ultrasound were able to detect bone erosions in 44% of patients with gout, with 78.4% of erosions occurring at the first metatarsophalangeal joints…
Meeting News

Failure to achieve serum urate target increases death risk in gout

October 25, 2018
CHICAGO — Patients with gout who fail to reach a serum urate target level of 6 mg/dL have a higher risk for death, according to Fernando Perez Ruiz, MD, PhD
More Headlines »

Updates in PsA and SpA: Optimizing Care Among the Latest Advances

This activity is supported by an educational grant from Lilly.

Chronic inflammatory diseases, such as psoriatic arthritis (PsA) and ankylosing spondylitis (AS), represent a group of…
More »
Meeting News

VIDEO: Calabrese discusses discoveries for gout

November 21, 2016
More »

Multidisciplinary Perspectives in Giant Cell Arteritis: A Team-based Approach for Improved Quality of Care

This activity is supported by an educational grant from Genentech, Inc.

Giant cell arteritis (GCA) is the most common form of medium- and large-vessel vasculitis. If left untreated, patients…
More »